| Objective: By analyzing hypoglycemia in patients with type 2 diabetes during hospitalization,this paper explores the factors that may cause hypoglycemia in inpatients with type 2 diabetes,explores the entry point of pharmaceutical care for type2 diabetes,assists clinicians to comprehensively control blood sugar,improves the comprehensive management level of type 2 diabetes,and provides a basis for the establishment of pharmaceutical care pathways for type 2 diabetes.In order to provide reference for optimizing blood glucose management of inpatients with diabetes,but also for clinical pharmacists to carry out the whole process of standardized pharmaceutical care to provide new ideas.Methods: The first part,from the perspective of patients and doctors,analyzed the factors affecting the occurrence of hypoglycemia in hospitalized patients with type 2diabetes.A total of 806 patients with type 2 diabetes admitted to the Department of Hospita from January 1,2021 to December 30,2021 were selected and divided into 176 patients with hypoglycemia group and 630 patients without hypoglycemia group according to whether they had experienced hypoglycemia during hospitalization.The electronic medical record system of our hospital was used to obtain the basic information and biochemical index results of enrolled patients,and the blood glucose monitoring system was used to collect the blood glucose monitoring data of patients.SPSS26.0 software was used to analyze influencing factors of hypoglycemia,and single factor Chi-square test and multiple logistic analysis were used to screen the main factors affecting hypoglycemia in patients with type 2 diabetes.The second part is to establish pharmaceutical care pathways for type 2 diabetes hypoglycemia,and provide pharmaceutical care for type 2 diabetes patients with hypoglycemia during hospitalization.Patients with type 2 diabetes and hypoglycemia were enrolled from October 2021 to June 2022.90 cases were randomly selected and divided into experimental group and control group in a ratio of 1:1.In addition to receiving inpatient medical care,inpatients in the experimental group were provided with pharmaceutical care by professional clinical pharmacists according to the proposed pharmaceutical care path,and follow-up was jointly completed by clinical pharmacists and clinicians after discharge.The inpatients in the control group only received inpatient medical services related to clinical routine management,and pharmaceutical follow-up after discharge was completed only by clinicians.Follow-up was set at 6 months after discharge.The observation indexes included fasting blood glucose,2 hours postprandial blood glucose,glycosylated hemoglobin and other clinical indexes as well as medication safety evaluation and medication compliance.General information of patients was collected through the electronic medical record system of our hospital,combined with questionnaires,and combined with pharmaceutical care and medication education to form a standardized pharmaceutical process for patients with type 2 diabetes and hypoglycemia.At the same time,new service methods such as face-to-face education of pharmacists combined with wechat interaction after discharge were introduced to provide effective reference for establishing reasonable and effective pharmaceutical care paths and promoting rational drug use.Results: Part I analysis of influencing factors of type 2 diabetes hypoglycemia results showed that: In this study,the proportion of type 2 diabetes inpatients with hypoglycemia was 21.80%,and fasting was the period of high incidence of hypoglycemia.Gender,long course of disease,low BMI,low Hb A1 c and multi-drug combination regimen all increase the risk of hypoglycemia in type 2 diabetes inpatients,which is also the key content of pharmaceutical care pathway establishment and medication education.Part II: Establishing pharmaceutical care paths for patients with type 2 diabetes and hypoglycemia during hospitalization.The results showed that medication compliance was significantly improved in the pharmaceutical intervention group during hospitalization(P <0.05).There were significant differences in the incidence of preventable and total adverse drug events(P <0.05).The satisfaction of medication guidance process was significantly increased(P <0.05),and the standard level of glycosylated hemoglobin was significantly different(P <0.05).The rate of return visit(or readmission)was not statistically significant(P >0.05).Conclusions: A comprehensive analysis was conducted to find the related factors affecting hypoglycemia in inpatients with type 2 diabetes,providing a new reference for ensuring the effective and safe treatment of type 2 diabetes.Through the analysis of influencing factors,pharmaceutical care and service path with more pertinence,feasibility and clinical reference value was developed.Through the development of pharmaceutical care,the effectiveness,compliance and satisfaction of treatment can be improved,which reflects the role of clinical pharmacists in pharmaceutical care for diabetic patients. |
